Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05889741 · ClinicalTrials.gov registry record · Phase 2
Combining Stellate Ganglion Block With Prolonged Exposure for PTSD
A Phase 2 study of Stress Disorders, Post-Traumatic, sponsored by The University of Texas Health Science Center at San Antonio.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
- 2
- Study locations
NCT05889741 is a Phase 2 study of Stress Disorders, Post-Traumatic that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 140 participants, roughly in line with the 154-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target. The trial reports 2 study locations across 1 state.
The verdict
NCT05889741, a Phase 2 study of Stress Disorders, Post-Traumatic, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to compare the combination of Massed Prolonged Exposure (PE); a behavioral therapy for PTSD) and a stellate ganglion block (SGB; an injection of a local anesthetic into the front of the neck) with Massed Prolonged Exposure and a sham injection in a sample of military service members or retirees with PTSD. The main questions it aims to answer are: (1) Does the addition of an SGB improve treatment outcomes associated with Massed PE and (2) Do differences in psychophysiological arousal during the exposure portion of treatment help explain treatment outcomes for PTSD. Participants will receive ten 90-minute session of Massed PE. Between the first and second Massed PE sessions, half of the participants will receive a SGB, and half will receive a sham SGB.
Conditions Studied
Interventions
- DRUG Normal saline
- DRUG Ropivacaine injection
Study Locations (2)
Texas
- Carl R. Darnall Army Medical Center - Fort Hood
- University of Texas Health Science Center at San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2027-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05889741
The ClinicalTrials.gov registry entry for NCT05889741 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 154-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 2 interventions - of which Normal saline is the first listed.
NCT05889741 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05889741 about?
NCT05889741 is a clinical study titled "Combining Stellate Ganglion Block With Prolonged Exposure for PTSD". The goal of this clinical trial is to compare the combination of Massed Prolonged Exposure (PE); a behavioral therapy for PTSD) and a stellate ganglion block (SGB; an injection of a local anesthetic into the front of the neck) with Massed Prolonged Exposure and a sham injection in a sample of milita...
What is the current status of trial NCT05889741?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2024-02-26. Estimated completion is 2027-08-31.
What conditions does trial NCT05889741 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT05889741?
The interventions under investigation include: Normal saline (DRUG), Ropivacaine injection (DRUG).
Who is sponsoring clinical trial NCT05889741?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05889741 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MDMA for Co-occurring PTSD and OUD After Childbirth
RECRUITING · Phase 2
-
A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD
ACTIVE NOT RECRUITING · Phase 2
-
Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
ACTIVE NOT RECRUITING · Phase 2
-
Prolonged Exposure Therapy for Post Traumatic Stress Disorder Following Sexual Assault
COMPLETED · Phase 2
-
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
COMPLETED · Phase 2
-
Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.